RELATED CONTENT
NEWS
- US Capitol Capsule: Senate & Supreme Court tackle issues of US patent system
- Amgen resolves patent suit, squashing Teva's neutropenia biosimilar until 2013
- Supreme Court justices question lack of Bayh-Dole rules for assigning rights
- NICE to review Fabre's Javlor again as comparison with unlicensed drugs deemed unfair
FEATURES
Other Informa Features


